Echo Street Capital Management LLC Horizon Therapeutics Public LTD CO Transaction History

Echo Street Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $7,146 - $10,472	-90 Reduced 0.77%	11,529 $920,000
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $787,718 - $1 Million	9,115 Added 364.02%	11,619 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $61,304 - $74,584	-622 Reduced 19.9%	2,504 $270,000
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $210,657 - $252,968	-2,292 Reduced 42.3%	3,126 $342,000
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $467,248 - $519,694	5,418 New	5,418 $507,000
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $439,741 - $636,402	-7,962 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $240,452 - $453,674	7,962 New	7,962 $443,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.